BIO-DIS Reciprocating Cylinder Apparatus - DATA SHEET

Importance of Topic

Extended release dosage forms demand reliable dissolution data to predict performance, support formulation development, and ensure regulatory compliance. The BIO-DIS Reciprocating Cylinder Apparatus provides automated, biorelevant testing across multiple pH conditions, addressing industry needs for robust quality control and in vitro–in vivo correlation.

Study Objectives and Overview

This summary presents the design, features, and operational workflow of Agilent’s BIO-DIS Reciprocating Cylinder for USP Apparatus 3 and EP reciprocating cylinder dissolution testing, highlighting its capacity for unattended, multi‐day profiling of extended release solids.

Methodology and Instrumentation

The apparatus moves up to seven sample cylinders sequentially through six media rows, each row containing a distinct dissolution medium. Key programmable parameters include dip speed, row dwell time, drain and hold‐dip intervals. The system can store 15 test programs and operate continuously for up to six days. Optional accessories enable temperature control, automated sampling, and alternate volume configurations.

Used Instrumentation

• BIO-DIS Reciprocating Cylinder Apparatus (100/300 mL standard or 1 L version)
• 750D Heater/Circulator for temperature regulation
• 8000 Dissolution Sampling Station with peristaltic or syringe pump
• 808 Filter Changer and 806 Syringe Pump for automated filtration
• Conversion kits for 100 mL, 1 L, and dual‐row configurations

Main Results and Discussion

The BIO-DIS delivers reproducible dissolution profiles for pellets, tablets, and capsules under biorelevant agitation and pH progression. Automated sample transport eliminates manual intervention, reducing variability and labor requirements. The flexible design accommodates poorly soluble or low‐dose formulations via optional volume and mesh adjustments. Integrated printing and digital displays provide real‐time monitoring and documentation.

Benefits and Practical Applications

• Biorelevant dissolution pH profiling for extended release products
• High throughput with minimal operator involvement
• Broad formulation compatibility including pellets, tablets, capsules
• Scalable volumes for low‐dose or poorly soluble drug testing
• Regulatory compliance with USP Apparatus 3 and EP specifications

Future Trends and Opportunities

Integration of advanced in vitro–in vivo correlation (IVIVC) models and machine learning for predictive dissolution analysis may enhance formulation screening. Development of fully automated workflows combining dissolution, sampling, and high‐throughput analytics will further streamline quality assessment. Expansion into physiologically based bioreactors and microfluidic media transitions could offer deeper insights into gastrointestinal dynamics.

Conclusion

Agilent’s BIO-DIS Reciprocating Cylinder offers a robust, automated solution for extended release dissolution testing under biorelevant conditions. Its programmability, flexible configurations, and compliance with global standards make it a valuable tool for research, development, and quality control laboratories seeking reliable dissolution data.